Cargando…
Poor Prognosis of Diffuse Large B-Cell Lymphoma with Hepatitis C Infection
Background: Hepatitis C virus (HCV) in diffuse large B-cell lymphoma (DLBCL) is associated with a higher prevalence and distinctive clinical characteristics and outcomes. Methods: A retrospective analysis of adult DLBCL patients from 2011 to 2015 was studied. Results: A total of 206 adult DLBCL were...
Autores principales: | Tsai, Yu-Fen, Liu, Yi-Chang, Yang, Ching-I, Chuang, Tzer-Ming, Ke, Ya-Lun, Yeh, Tsung-Jang, Gau, Yuh-Ching, Du, Jeng-Shiun, Wang, Hui-Ching, Cho, Shih-Feng, Hsu, Chin-Mu, Wu, Pey-Fang, Huang, Ching-I, Huang, Chung-Feng, Yu, Ming-Lung, Dai, Chia-Yen, Hsiao, Hui-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465128/ https://www.ncbi.nlm.nih.gov/pubmed/34575621 http://dx.doi.org/10.3390/jpm11090844 |
Ejemplares similares
-
Low Geriatric Nutritional Risk Index Is Associated with Poorer Prognosis in Elderly Diffuse Large B-Cell Lymphoma Patients Unfit for Intensive Anthracycline-Containing Therapy: A Real-World Study
por: Chuang, Tzer-Ming, et al.
Publicado: (2021) -
Revisit of the Association between Cytomegalovirus Infection and Invasive Fungal Infection after Allogeneic Hematopoietic Stem Cell Transplantation: A Real-World Analysis from a High CMV Seroprevalence Area
por: Yeh, Tsung-Jang, et al.
Publicado: (2022) -
The Cost-Effectiveness Analysis of Transplant-Ineligible Myeloma Patients with Bortezomib plus Thalidomide plus Dexamethasone (VTD) or Bortezomib plus Melphalan plus Prednisolone (VMP) Treatment in Southern Taiwan
por: Du, Jeng-Shiun, et al.
Publicado: (2022) -
Emodin Ameliorates the Efficacy of Carfilzomib in Multiple Myeloma Cells via Apoptosis and Autophagy
por: Hsu, Chin-Mu, et al.
Publicado: (2022) -
Calreticulin Mutation Survey by High Resolution Melting Method Associated with Unique Presentations in Essential Thrombocythemic Patients
por: Liu, Yi-Chang, et al.
Publicado: (2020)